tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports

Aprea Therapeutics (APRE) Income Statement

500 Followers

Aprea Therapeutics Income Statement

Last quarter (Q4 2025), Aprea Therapeutics's total revenue was $3.34K, a decrease of -98.38% from the same quarter last year. In Q4, Aprea Therapeutics's net income was $-2.46M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 285.76K$ 1.50M$ 583.23K$ 0.00$ 0.00
Gross Profit
$ 264.04K$ -7.86M$ 576.18K$ -16.40M$ -271.68K
Operating Expenses
$ 13.52M$ 6.46M$ 16.05M$ 96.99M$ 37.17M
Depreciation and Amortization
$ 21.71K$ 22.32K$ 7.05K$ 4.40K$ 271.68K
EBITDA
$ -13.23M$ -14.30M$ -14.28M$ -37.37M$ -36.86M
Operating Income
$ -13.23M$ -14.32M$ -15.47M$ -113.39M$ -37.45M
Other Income/Expenses
$ 634.27K$ 1.36M$ 1.19M$ 730.20K$ 319.05K
Pretax Income
$ -12.60M$ -12.96M$ -14.29M$ -112.66M$ -37.13M
Net Income
$ -12.60M$ -12.96M$ -14.29M$ -112.66M$ -36.54M
Per Share Metrics
Basic EPS
$ -1.93$ -2.35$ -3.95$ -1.36K$ -34.88
Diluted EPS
$ -1.93$ -2.35$ -3.95$ -1.36K$ -34.88
Weighted Average Shares Outstanding
 6.54M 5.51M 3.62M 82.85K 1.06M
Weighted Average Shares Outstanding (Diluted)
 6.54M 5.51M 3.62M 82.85K 1.06M
Currency in USD

Aprea Therapeutics Earnings and Revenue History